FDA Approves Groundbreaking Twice-Yearly HIV Prevention Shot, Yeztugo (Lenacapavir)
In a landmark development in the global fight against HIV, the U.S. Food and Drug Administration (FDA) has approved Yeztugo (lenacapavir) — the world’s first twice-yearly injectable for ...

